Broadly neutralizing anti-HIV monoclonal antibody PGT 121_2011 data

Instructions | Symbol Definitions | Lipid Tag Descriptions
(Asterisks that follow the names of certain probes indicate that predominant components are shown.)

Sort By Value
Display Errors
5 fmol (mauve) 2 fmol (blue)
Textual Symbolic

Experiment Name	Broadly neutralizing anti-HIV monoclonal antibody PGT 121_2011 data
Associated Publication	Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies. Mouquet H, Scharf L, Euler Z, Liu Y, Eden C, Scheid JF, Halper-Stromberg A, Gnanapragasam PN, Spencer DI, Seaman MS, Schuitemaker H, Feizi T, Nussenzweig MC, Bjorkman PJ Proceedings of the National Academy of Sciences of the United States of America, 109, E3268-77 2012 Nov 20
Analyte Name	PGT 121
Analyte Family	Antibodies
Analyte Information	One of the human HIV-1 broad and potent neutralizing IgG antibodies isolated from HIV-1-infected individuals by single-cell sorting and neutralization screen and appears to bind to an Asn332 glycan-dependent epitope on gp120.
Concentration	50 ug/mL
Protocol	After blocking arrayed slides with 0.04% (v/v) Blocker Casein (Pierce), 1% (w/v) bovine serum albumin (Sigma A8577) in Hepes buffered saline (5 mM Hepes, pH 7.4, 150 mM NaCl, 5 mM CaCl2), PGT121 was analyzed at 50 ug/ml, followed by biotinylated anti-human IgG (Vector) 5 ug/ml. Binding was detected using Alexa Fluor-647-labeled streptavidin from Molecular Probes (1 ug/ml). As diluent the blocker solution was used.
Other Comments	N/A